EUVIMEDEUVIMED entdecken
Crossref

Prospectively Specified Adaptive Bayesian Borrowing: Considerations, Methodologies, and Implementations

Saurabh Mukhopadhyay iD, Yujie Zhao iD, Xiaotian Chen, Anthony J Cannon, Julie Adams, Martina Kron

Pharmaceutical Statistics · 2026

DOI: 10.1002/pst.70051 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Statistics, 2026. Verfasst von Saurabh Mukhopadhyay und 5 weiteren Autor:innen. Beteiligte Einrichtung: AbbVie Inc, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Research Design, Randomized Controlled Trials as Topic. Die Arbeit nennt 20 Literaturangaben. Gefördert von: AbbVie.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In clinical research, it is increasingly difficult to conduct fully powered and well‐balanced randomized controlled trials, particularly when studying rare or devastating diseases and pediatric patients. While Bayesian methodologies are very useful for leveraging historical control data to meet some of these challenges, many practical and statistical concerns emerge when prospectively specifying a design to implement Bayesian methods. In this article, we discuss these concerns and propose novel methods to ensure statistical rigor when applying Bayesian methodology. A novel adaptive Bayesian borrowing (ABB) method proposed here borrows from historical control data to increase the precision of the control arm based on the observed congruence of the historical and current data. The method would also enable an adaptive increase of sample size to accommodate accumulating information. We demonstrate that this approach can be prospectively specified and provides a statistically rigorous and transparent inference while mitigating the risk of potential conflict between historical and current control data, as well as misspecifications of variability in the endpoints.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Research DesignRandomized Controlled Trials as TopicBayes TheoremHumansSample SizeProspective StudiesData Interpretation, StatisticalModels, Statistical

Stichwörter der Autor:innen

MAP priorsadaptive Bayesian borrowingblinded sample size re‐estimationclinical trialsleveraging historical control

Autor:innen und Institutionen

  • AbbVie Inc, Chicago, Illinois, USA.
  • AbbVie Germany GmbH & Co. KG, Ludwigshafen, Germany.

ORCID-Profile: Saurabh Mukhopadhyay, Yujie Zhao

Förderung

  • AbbVie

Zitieren

APA

Mukhopadhyay, S., Zhao, Y., Chen, X., Cannon, A. J., Adams, J., & Kron, M. (2026). Prospectively Specified Adaptive Bayesian Borrowing: Considerations, Methodologies, and Implementations. Pharmaceutical Statistics. https://doi.org/10.1002/pst.70051

Vancouver

Mukhopadhyay S, Zhao Y, Chen X, Cannon AJ, Adams J, Kron M. Prospectively Specified Adaptive Bayesian Borrowing: Considerations, Methodologies, and Implementations. Pharmaceutical Statistics. 2026. doi:10.1002/pst.70051

BibTeX
@article{Mukhopadhyay2026,
  author = {Mukhopadhyay, Saurabh and Zhao, Yujie and Chen, Xiaotian and Cannon, Anthony J and Adams, Julie and Kron, Martina},
  title = {Prospectively Specified Adaptive Bayesian Borrowing: Considerations, Methodologies, and Implementations},
  journal = {Pharmaceutical Statistics},
  year = {2026},
  doi = {10.1002/pst.70051}
}
Kostenlos starten →